Transfer of the cytidine deaminase cDNA into hematopoietic cells

被引:20
作者
Flasshove, M [1 ]
Frings, W [1 ]
Schröder, JK [1 ]
Moritz, T [1 ]
Schütte, J [1 ]
Seeber, S [1 ]
机构
[1] Univ Essen Gesamthsch, Sch Med, W German Canc Ctr, Dept Internal Med Canc Res, D-45122 Essen, Germany
关键词
drug resistance; gene therapy; cytidine deaminase; retroviral vector; hematopoiesis; cytosine arabinoside;
D O I
10.1016/S0145-2126(99)00128-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to investigate whether transfer of the cytidine deaminase (CDD) cDNA would increase chemotherapy resistance to cytosine arabinoside (ara-C) we used a retroviral vector expressing both, neomycin phosphotransferase and the CDD cDNA, to transduce hematopoietic cells from cell lines and from murine bone marrow (BM). After coculture on producer clones with a viral titer of 1 x 10(5) CFU/ml and up to 3-fold increased CDD enzymatic activity, WEHI-3 cell line and primary hematopoietic cells were exposed to ara-C in clonogenic assays. A transduction efficiency of 34.8 +/- 6.2% could be determined for BM clonogenic progenitor cells by G418 resistance. We could observe significantly more colonies (77 +/- 3.1%) surviving from transduced primary BM cells than from mock cells (51.7 +/- 9.3%) at 10(-8) mol/l ara-C, At 10(-7) mol/l ara-C 8.7% of BM cells became absolutely resistant after retroviral transduction. Our data confirm that CDD represents another candidate gene for increasing resistance to cytotoxic drugs in hematopoietic cells. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 41 条
[1]   RETROVIRAL TRANSDUCTION AND EXPRESSION OF THE HUMAN ALKYLTRANSFERASE CDNA PROVIDES NITROSOUREA RESISTANCE TO HEMATOPOIETIC-CELLS [J].
ALLAY, JA ;
DUMENCO, LL ;
KOC, ON ;
LIU, L ;
GERSON, SL .
BLOOD, 1995, 85 (11) :3342-3351
[2]   HUMAN GENE-THERAPY [J].
ANDERSON, WF .
SCIENCE, 1992, 256 (5058) :808-813
[3]   NOVEL RETROVIRAL VECTORS FOR EFFICIENT EXPRESSION OF THE MULTIDRUG-RESISTANCE (MDR-1) GENE IN EARLY HEMATOPOIETIC-CELLS [J].
BAUM, C ;
HEGEWISCHBECKER, S ;
ECKERT, HG ;
STOCKING, C ;
OSTERTAG, W .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7541-7547
[4]   Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate [J].
Beauséjour, CM ;
Le, NLO ;
Létourneau, S ;
Cournoyer, D ;
Momparler, RL .
HUMAN GENE THERAPY, 1998, 9 (17) :2537-2544
[5]   RETROVIRUS-MEDIATED TRANSFER OF THE MULTIDRUG-RESISTANCE GENE INTO HUMAN HEMATOPOIETIC PROGENITOR CELLS [J].
BERTOLINI, F ;
DEMONTE, L ;
CORSINI, C ;
LAZZARI, L ;
LAURI, E ;
SOLIGO, D ;
WARD, M ;
BANK, A ;
MALAVASI, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) :318-324
[6]   Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: A review and updated results of the Australian Leukemia Study Group [J].
Bishop, JF ;
Matthews, JP ;
Young, GAR ;
Bradstock, K ;
Lowenthal, RM .
LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) :315-327
[7]   GENE MARKING TO DETERMINE WHETHER AUTOLOGOUS MARROW INFUSION RESTORES LONG-TERM HEMATOPOIESIS IN CANCER-PATIENTS [J].
BRENNER, MK ;
RILL, DR ;
HOLLADAY, MS ;
HESLOP, HE ;
MOEN, RC ;
BUSCHLE, M ;
KRANCE, RA ;
SANTANA, VM ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 342 (8880) :1134-1137
[8]   Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice [J].
Bunting, KD ;
Galipeau, J ;
Topham, D ;
Benaim, E ;
Sorrentino, BP .
BLOOD, 1998, 92 (07) :2269-2279
[9]  
CAPIZZI RL, 1991, SEMIN HEMATOL, V28, P54
[10]   HELPER VIRUS-INDUCED T-CELL LYMPHOMA IN NONHUMAN-PRIMATES AFTER RETROVIRAL MEDIATED GENE-TRANSFER [J].
DONAHUE, RE ;
KESSLER, SW ;
BODINE, D ;
MCDONAGH, K ;
DUNBAR, C ;
GOODMAN, S ;
AGRICOLA, B ;
BYRNE, E ;
RAFFELD, M ;
MOEN, R ;
BACHER, J ;
ZSEBO, KM ;
NIENHUIS, AW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1125-1135